Life Sciences Blog
As Seen In
In an interview with The Lawyer, WSG member Simon McArdle, Partner at Shoosmiths, shares his advice to GCs for initial approach to implementation of legal tech solutions. McArdle gives his advice on how to ensure the best strategic implementation...
Services
Region
Industries
- Agriculture
- Corporate & Business
- Crossborder Trade & Investment
- Dispute Resolution
- Employment & Labor
- Energy & Natural Resources
- Environmental
- Financial Services
- Government & Public Sector
- Healthcare & Pharmaceuticals
- Hospitality, Media & Leisure
- Industrial & Manufacturing
- Insurance
- Life Sciences
- Real Estate & Construction
- Retail & Distribution
- Taxation
- Technology
- Telecommunications
- Transportation
Recent Posts
- Blog: Homeostasis: Dykema Health Care Law BlogU.S. Supreme Court Upholds the CMS COVID-19 Vaccine MandatePosted on January 14, 2022 by Kathleen A. ReedOn January 13, 2022, the United State Supreme Court upheld the Department of Health and Humans Services (“HHS”) Centers for Medicare and Medicaid Services (“CMS”) COVID-19 vaccine mandate for staff working at Medicare-participating health care facilities. HHS/CMS had issued an interim final rule on November 5, 2021, that incorporated a vaccine mandate into the health... Continue Reading
- Blog: Ireland IP & Technology Law BlogNew Deal for EU Consumers- the Omnibus Directive explainedPosted on October 28, 2021 by Emma CreavenThe new Enforcement and Modernisation Directive 2019/2161, more commonly known as the ‘Omnibus Directive’ (the Directive), aims to strengthen consumer rights through enhanced enforcement measures and increased transparency requirements. Key dates EU Member States must adopt national implementation measures by 28 November 2021. The new requirements set out in the Directive must then come into...Continue Reading…
- Blog: Biologics BlogFederal Circuit Upholds Jury Award, Weighs in on Willfulness Standard, in Adynovate® DisputePosted on March 29, 2021 by According to the Federal Circuit, $173 million was the right damages award for almost three years of patent infringement resulting from Baxalta’s sale of its biologic product Adynovate® (Antihemophilic Factor (Recombinant), PEGylated). In Bayer Healthcare LLC v. Baxalta Inc., et al., Nos. 2019-2418, 2020-1017 (Fed. Cir. 2021), the circuit court upheld an award to Bayer [...]
